Fibrosarcoma |
ICR scid |
HT-1080 |
J Cachexia Sarcopenia Muscle 2020 12;11(6):1813-1829 |
Glioma |
C.B-17 scid |
BT-40 |
Oncotarget. 2015 |
Glioma |
C.B-17 scid |
BT-40 |
Pediatr Blood Cancer. 2015 Oct |
Glioma |
C.B-17 scid |
BT-40 |
Clin Cancer Res. 2013 Dec 15 |
Glioma |
NCr nude |
A-172 |
Neuro Oncol. 2009 Apr |
Lung |
Rag2/Il2rg Double Knockout (B6;B10) |
NCI-H358 |
J Biol Chem . 2011 Feb 11 |
Lung |
NCr nude |
A549 |
J Biol Chem . 2011 Feb 11 |
Lung |
Rag2/Il2rg Double Knockout (B6;B10) |
A549 |
J Biol Chem . 2011 Feb 11 |
Lung |
C.B-17 scid |
NCI-H1299 |
Int J Nanomedicine. 2016 |
Breast |
NCr nude |
MDA-MB-231 |
PLoS One . 2014 Jun 27 |
Prostate |
NMRI nude |
PC-82 |
J Nucl Med . 2007 Jan |
Prostate |
NMRI nude |
PC-310 |
J Nucl Med . 2007 Jan |
Prostate |
NMRI nude |
PC-295 |
J Nucl Med . 2007 Jan |
Osteosarcoma |
Scid-beige |
MNNG-HOS |
Oncogene. 2009 Sep 24 |
Osteosarcoma |
C.B-17 scid |
SaOS-LM7 |
PLoS One. 2017 |
Adenocarcinoma |
NCr nude |
KB-C2 |
Cancer Lett. 2013 Jan 28 |
Adenocarcinoma |
NCr nude |
KB-3-1 |
Cancer Lett. 2013 Jan 28 |
Leukemia |
NCr nude |
HL-60 |
Blood . 1998 Apr 1 |
Kidney |
NCr nude |
786-O |
Cancer Chemother Pharmacol . 2007 Apr |
Prostate |
Rag2 (C57BL/6) |
PC-3 |
ACS Cent Sci . 2019 Apr 24 |
Glioblastoma |
Swiss nude |
U 87 MG |
J Pharmacol Exp Ther. 2012 Nov |
Breast |
NCr nude |
MCF-7 |
Endocrinology . 1998 Apr |
Breast |
NMRI nude |
M4A4-LM |
PLoS ONE 2010 Sep 30 |
Melanoma |
NCr nude |
WM9 |
J. Natl. Cancer Inst. 2002 Jul 03 |
Prostate |
C.B-17 scid |
VCaP |
Clin. Cancer Res. 2018 May 15 |
Lung |
NCr nude |
SK-MES-1 |
Clin. Cancer Res. 2011 May 15 |
Pancreatic |
NCr nude |
BxPC-3 |
Clin. Cancer Res. 2011 May 15 |
Pancreatic |
NCr nude |
Capan-1 |
Clin. Cancer Res. 2011 May 15 |
Colon |
NCr nude |
COLO 205 |
Clin. Cancer Res. 2011 May 15 |
Stomach |
C.B-17 scid |
MKN28 |
Clin. Cancer Res. 2006 May 15 |
Melanoma |
C.B-17 scid |
SK-MEL-5 |
Cancer Res. 2012 Oct 01 |
Melanoma |
C.B-17 scid |
A-375 |
Cancer Res. 2012 Oct 01 |
Lung |
NMRI nude |
NYH |
BMC Cancer 2010 Dec 12 |
Colon |
NMRI nude |
HCT 116 |
BMC Cancer 2010 Dec 12 |
Lymphoma |
CIEA NOG mouse® |
HUT78 |
Blood 2014 Mar 06 |
Lymphoma |
CIEA NOG mouse® |
My-La |
Blood 2014 Mar 06 |
Mesothelioma |
Scid-beige |
LRK1A |
Am. J. Respir. Cell Mol. Biol. 2008 Jun |
Leukemia |
CIEA NOG mouse® |
MT-2 |
J. Virol. 2003 May |
Leukemia |
CIEA NOG mouse® |
MT-4 |
J. Virol. 2003 May |
Leukemia |
CIEA NOG mouse® |
SLB-1 |
J. Virol. 2003 May |
Leukemia |
NOD scid |
NB4 |
Leukemia 2004 Mar |
Lymphoma |
BALB/c nude |
BC-3 |
J. Clin. Invest. 2007 Apr |
Carcinoma |
NCr nude |
A-498 |
Radiology 2009 Jun |
Clear Cell Carcinoma |
NCr nude |
Caki-1 |
Radiology 2009 Jun |
Breast |
NMRI nude |
MDA-MB-435 |
Neuro-oncology 2009 Apr |
Glioblastoma |
NMRI nude |
U373 MG |
Neuro-oncology 2009 Apr |
Cervical |
NMRI nude |
HeLa |
Neuro-oncology 2009 Apr |
Neuroblastoma |
C.B-17 scid |
NGP |
J Pediatr Hematol Oncol . 2014 Jan |
Neuroblastoma |
C.B-17 scid |
SY5Y |
J Pediatr Hematol Oncol . 2014 Jan |
Glioblastoma |
C.B-17 scid |
LN229 |
PLoS One . 2017 Apr 28 |
Glioblastoma |
NCr nude |
U 251 HF |
J Neurooncol. 2010 Jan |
Glioblastoma |
NCr nude |
U 87 vIII |
J Neurooncol . 2011 Jan |
Colon |
Swiss nude |
LS 174T |
Mol Cancer Ther . 2008 May |
Colon |
NCr nude |
HT-29 |
Gastroenterology . 2010 Oct |
Endometrial |
BALB/c nude |
AN3 CA |
Gynecol Oncol . 2014 Feb |
Colon |
NMRI nude |
HT-29 |
Mol Cancer Ther . 2016 Mar |
Osteosarcoma |
C.B-17 scid |
LM7 |
Mol Ther . 2009 Oct |
Breast |
NCr nude |
MCF-7 |
Cell Rep . 2019 Mar 5 |
Breast |
NCr nude |
T47D |
J Biol Chem . 2016 Dec 16 |
Breast |
NCr nude |
MCF-7 |
J Biol Chem . 2016 Dec 16 |
Breast |
NCr nude |
MDA-MB-231 |
J Biol Chem . 2016 Dec 16 |
Breast |
BALB/c nude |
MCF-7/5C |
J. Steroid Biochem. Mol. Biol. 2006 Dec |
Breast |
NCr nude |
MDA-MB-231 |
Neoplasia 2009 Jun |
Breast |
ICR scid |
MDA-MB-468 |
Mol. Cancer Ther. 2010 Jun |
Glioblastoma |
NCr nude |
T98G |
Neoplasia. 2009 Jan |
Glioblastoma |
NCr nude |
U 87 MG |
J Evid Based Complementary Altern Med 2016 Jul 19; |
Gallbladder |
NMRI nude |
CC-SW-1 |
Oncotarget 2017 Oct 27;8(52):89736-89745 |
Gallbladder |
NMRI nude |
Sk-ChA-1 |
Oncotarget 2017 Oct 27;8(52):89736-89745 |
Gallbladder |
NMRI nude |
MZ-ChA-1 |
Oncotarget 2017 Oct 27;8(52):89736-89745 |
Gallbladder |
NMRI nude |
EGI-1 |
Oncotarget 2017 Oct 27;8(52):89736-89745 |
Gallbladder |
NMRI nude |
TFK-1 |
Oncotarget 2017 Oct 27;8(52):89736-89745 |
Prostate |
NCr nude |
PC-3 |
Mol Imaging Biol 2016 06;18(3):402-10 |
Prostate |
NCr nude |
LNCaP |
Mol Imaging Biol 2016 06;18(3):402-10 |
Breast |
NCr nude |
MDA-MB-231 |
Sci Rep 2018 Feb 20;8(1):3321 |
Prostate |
NCr nude |
PC-3 |
Sci Rep 2018 Feb 20;8(1):3321 |
Prostate |
C.B-17 scid |
LNCaP |
Clin. Cancer Res. 2018 May 15;24(10):2408-2416 |
Prostate |
C.B-17 scid |
PC-3 |
Biol. Pharm. Bull. 2014;37(6):1029-34 |
Prostate |
C.B-17 scid |
LNCaP C4-2B |
Neoplasia 2008 Apr;10(4):371-80 |
Head and neck |
NCr nude |
FaDu |
Int J Hyperthermia 2010;26(5):485-98 |
Pancreatic |
NCr nude |
MIA PaCa-2 |
Clin. Cancer Res. 2009 Nov 01;15(21):6519-28 |
Pancreatic |
CIEA NOG mouse® |
PL45 |
Int. J. Oncol. 2007 Oct;31(4):741-51 |
Pancreatic |
CIEA NOG mouse® |
PANC-1 |
Int. J. Oncol. 2007 Oct;31(4):741-51 |
Pancreatic |
CIEA NOG mouse® |
MIA PaCa-2 |
Int. J. Oncol. 2007 Oct;31(4):741-51 |
Pancreatic |
CIEA NOG mouse® |
Capan-2 |
Int. J. Oncol. 2007 Oct;31(4):741-51 |
Pancreatic |
CIEA NOG mouse® |
Capan-1 |
Int. J. Oncol. 2007 Oct;31(4):741-51 |
Pancreatic |
CIEA NOG mouse® |
BxPC-3 |
Int. J. Oncol. 2007 Oct;31(4):741-51 |
Pancreatic |
CIEA NOG mouse® |
AsPC-1 |
Int. J. Oncol. 2007 Oct;31(4):741-51 |
Pancreatic |
NMRI nude |
MIA PaCa-2 |
Br. J. Cancer 2008 Jul 08;99(1):110-7 |
Pancreatic |
NCr nude |
PANC-1 |
Clin. Cancer Res. 2009 Aug 15;15(16):5136-44 |
Pancreatic |
NCr nude |
BxPC-3 |
Clin. Cancer Res. 2009 Aug 15;15(16):5136-44 |
Pancreatic |
NMRI nude |
MIA PaCa-2 |
Int J Pharm 2013 Jan 30;441(1-2):499-506 |
Pancreatic |
NMRI nude |
L3.6pl |
World J. Gastroenterol. 2008 Jun 21;14(23):3681-92 |
Pancreatic |
NMRI nude |
HPAF-II |
World J. Gastroenterol. 2008 Jun 21;14(23):3681-92 |
Ovarian |
NCr nude |
A2780 |
Am. J. Pathol. 2009 Apr;174(4):1504-14 |
Ovarian |
NMRI nude |
A2780 |
PLoS ONE 2013;8(12):e85126 |
Ovarian |
NMRI nude |
A2780 |
APMIS 2008 May;116(5):382-92 |
Ovarian |
NMRI nude |
A2780 |
PLoS ONE 2010 Sep 24;5(9):e12965 |
Ovarian |
ICR scid |
OVCAR-3 |
J Labelled Comp Radiopharm 2009 Dec 01;52(14):583-590 |
Ovarian |
BALB/c nude |
TOV-21G |
Br. J. Cancer 2015 Feb 03;112(3):504-13 |
Ovarian |
BALB/c nude |
TOV-112D |
Br. J. Cancer 2015 Feb 03;112(3):504-13 |
Ovarian |
NCr nude |
OVCAR-3 |
J. Natl. Cancer Inst. 2002 Jul 03;94(13):1010-9 |
Neuroblastoma |
C.B-17 scid |
SK-N-AS |
J. Pediatr. Surg. 2013 Jan;48(1):39-46 |
Neuroblastoma |
C.B-17 scid |
NB-1691 |
J. Pediatr. Surg. 2013 Jan;48(1):39-46 |
Neuroblastoma |
C.B-17 scid |
CHLA-20 |
J. Pediatr. Surg. 2013 Jan;48(1):39-46 |
Neuroblastoma |
BALB/c nude |
SK-N-AS |
Oncogene 2009 Jan 29;28(4):479-91 |
Myeloma |
C.B-17 scid |
INA-6 |
Blood 2005 Jul 15;106(2):713-6 |
Lung |
CIEA NOG mouse® |
NCI-H292 |
Oncotarget 2017 Feb 07;8(6):9488-9499 |
Colon |
CIEA NOG mouse® |
HCT 116 |
Nitric Oxide 2015 Apr 30;46:102-13 |
Leukemia |
CIEA NOG mouse® |
VR-ALL |
Oncotarget 2018 04 06;9(26):18341-18350 |
Leukemia |
CIEA NOG mouse® |
43Tb(-) |
Retrovirology 2015 Nov 24;12:99 |
Leukemia |
CIEA NOG mouse® |
TL-OML |
Retrovirology 2015 Nov 24;12:99 |
Leukemia |
CIEA NOG mouse® |
SLB-1 |
Retrovirology 2015 Nov 24;12:99 |
Colon |
CIEA NOG mouse® |
HCT 116 |
J. Immunol. 2015 Aug 15;195(4):1883-90 |
Lymphoma |
CIEA NOG mouse® |
SNK6 |
Clin. Cancer Res. 2014 Nov 01;20(21):5412-22 |
Breast |
CIEA NOG mouse® |
MDA-MB-231 |
Mol. Pharm. 2014 Nov 03;11(11):3988-95 |
Breast |
CIEA NOG mouse® |
SK-BR-3 |
Mol. Pharm. 2014 Nov 03;11(11):3988-95 |
Breast |
CIEA NOG mouse® |
BT-474 |
Mol. Pharm. 2014 Nov 03;11(11):3988-95 |
Colon |
CIEA NOG mouse® |
HCT116/venus |
Anal Bioanal Chem 2011 Jun;400(7):1895-904 |
Colon |
CIEA NOG mouse® |
HCT 116 |
Oncol. Rep. 2013 Feb;29(2):464-8 |
Colon |
CIEA NOG mouse® |
Fucci-HCT116 |
Mol. Cancer Res. 2013 Sep;11(9):973-85 |
Breast |
NMRI nude |
M4A4-LM |
Int. J. Cancer 2007 Jul 01;121(1):165-74 |
Neuroblastoma |
NMRI nude |
SK-N-FI |
Hum. Gene Ther. 2013 Aug;24(8):766-75 |
Colon |
NOD scid |
SW620 |
BMC Cancer 2012 Mar 20;12:96 |
Prostate |
NMRI nude |
DU145 |
Am J Nucl Med Mol Imaging 2014;4(4):311-23 |
Prostate |
NMRI nude |
PC-3 |
Am J Nucl Med Mol Imaging 2014;4(4):311-23 |
Gallbladder |
NMRI nude |
Mz-ChA-2 |
Oncotarget 2017 Oct 27;8(52):89736-89745 |
Breast |
NMRI nude |
MCF-7 |
Diagnostics (Basel) 2012 Oct 09;2(4):42-51 |
Prostate |
NMRI nude |
PC346-DCC-K |
EBioMedicine 2018 Jan;27:182-186 |
Colon |
C.B-17 scid |
HT-29 |
Cancer Gene Ther. 2012 Feb;19(2):126-34 |
Colon |
NMRI nude |
HCT 116 |
Cancer Gene Ther. 2012 Feb;19(2):126-34 |
Prostate |
NMRI nude |
PC3-MM2 |
Clin. Cancer Res. 2009 Sep 01;15(17):5396-403 |
Prostate |
NMRI nude |
PC3-MM2 |
PLoS ONE 2012;7(3):e32871 |
Breast |
NMRI nude |
SUM149PT |
Mol. Cancer Ther. 2016 04;15(4):583-92 |
Lung |
NMRI nude |
NCI-H1299 |
Mol. Cancer Ther. 2016 04;15(4):583-92 |
Ovarian |
NMRI nude |
A2780cis |
Mol. Cancer Ther. 2016 04;15(4):583-92 |
Stomach |
NMRI nude |
MKN45 |
Clin. Cancer Res. 2006 May 15;12(10):3137-44 |
Neuroblastoma |
Scid-beige |
SK-N-SH |
J. Virol. 2011 Dec;85(24):13114-23 |
Ovarian |
NMRI nude |
A2780 |
Mol. Cancer Ther. 2010 Jun;9(6):1609-17 |
Leukemia |
NMRI nude |
ML-2 |
Mol. Cancer Ther. 2010 Jun;9(6):1609-17 |
Prostate |
NMRI nude |
PC-346C |
Eur. Urol. 2015 Jun;67(6):1177-1185 |
Gallbladder |
NMRI nude |
Mz-ChA-2 |
World J. Gastroenterol. 2007 Sep 21;13(35):4761-70 |
Cholangiocarcinoma |
NMRI nude |
EGI-1 |
World J. Gastroenterol. 2007 Sep 21;13(35):4761-70 |
Breast |
NMRI nude |
MCF-7 |
BMC Med Imaging 2008 Oct 16;8:16 |
Head and neck |
NMRI nude |
FaDu |
Clin. Cancer Res. 2008 Jul 15;14(14):4584-92 |
Cholangiocarcinoma |
NMRI nude |
EGI-1 |
World J. Gastroenterol. 2006 Mar 14;12(10):1583-90 |
Gallbladder |
NMRI nude |
Mz-ChA-2 |
World J. Gastroenterol. 2006 Mar 14;12(10):1583-90 |
Leukemia |
NCr nude |
Jurkat |
In Vivo 25(4):603-7 |
Glioblastoma |
NMRI nude |
U 87 MG |
Nucl. Med. Biol. 2014 Mar;41(3):259-67 |
Lung |
NMRI nude |
NCI-H727 |
Nucl. Med. Biol. 2014 Mar;41(3):259-67 |
Ovarian |
NCr nude |
A2780/CP70 |
J Ovarian Res 2011 Jun 22;4:9 |
Breast |
NCr nude |
BT-20 |
Mol. Cancer Ther. 2009 Mar;8(3):672-81 |
Breast |
NCr nude |
MCF-7 |
Mol. Cancer Ther. 2009 Mar;8(3):672-81 |
Astrocytoma |
NMRI nude |
U-251MG |
BMC Cancer 2012 Jun 13;12:242 |
Lymphoma |
Scid-beige |
Raji |
Clin. Cancer Res. 2007 Sep 15;13(18 Pt 1):5426-35 |
Leukemia |
Scid-beige |
NALM-6 |
Clin. Cancer Res. 2007 Sep 15;13(18 Pt 1):5426-35 |
Leukemia |
Scid-beige |
HL-60 |
Leukemia 2012 Aug;26(8):1771-8 |
Lung |
NCr nude |
Calu-3 |
Clin. Cancer Res. 2011 May 15;17(10):3157-69 |
Lymphoma |
ICR scid |
WSU-DLCL2 |
J Hematol Oncol 2009 Feb 16;2:8 |
Lymphoma |
ICR scid |
WSU-DLCL2 |
Clin. Cancer Res. 2009 Jun 15;15(12):4038-45 |
Lymphoma |
ICR scid |
WSU-FSCCL |
Clin. Cancer Res. 2009 Jun 15;15(12):4038-45 |
Liver |
C.B-17 scid |
Hep 3B2.1-7 |
PLoS ONE 2013;8(7):e68506 |
Liver |
C.B-17 scid |
Hep-G2 |
PLoS ONE 2013;8(7):e68506 |
Lymphoma |
C.B-17 scid |
Namalwa |
Clin. Cancer Res. 2004 Feb 01;10(3):1100-11 |
Head and neck |
NCr nude |
FaDu |
Cancer Res. 2000 Dec 15;60(24):6950-7 |
Stomach |
NCr nude |
NCI-N87 |
Clin. Cancer Res. 2015 Nov 15;21(22):5131-8 |
Pancreatic |
NCr nude |
Capan-1 |
Clin. Cancer Res. 2015 Nov 15;21(22):5131-8 |
Melanoma |
C.B-17 scid |
A-375 |
Clin. Cancer Res. 2007 Dec 01;13(23):7217-23 |
Liver |
NIH nude rat |
Huh-7.5 |
Cancer Biol. Ther. 2009 May;8(9):856-65 |
Lung |
BALB/c nude |
HCC827 |
Cancer Res. 2009 Feb 01;69(3):873-8 |
Lung |
BALB/c nude |
NCI-H358 |
Cancer Res. 2009 Feb 01;69(3):873-8 |
Lung |
BALB/c nude |
A549 |
Cancer Res. 2009 Feb 01;69(3):873-8 |
Melanoma |
ICR scid |
DB-1 |
Cancer Res. 2000 Jul 01;60(13):3532-6 |
Prostate |
NCr nude |
PC-3 |
PLoS ONE 2010 Mar 31;5(3):e9885 |
Prostate |
NOD scid |
DU145 |
Gene Ther. 2010 Aug;17(8):1042-51 |
Prostate |
C.B-17 scid |
PC-3 |
J. Exp. Clin. Cancer Res. 2009 Jan 12;28:6 |
Prostate |
ICR scid |
PC-3 |
Bioconjug. Chem. 2008 Oct;19(10):2040-8 |
Prostate |
BALB/c nude |
LNCaP |
BMC Genomics 2009 Oct 15;10:476 |
Prostate |
ICR scid |
PC-3 |
Am. J. Pathol. 2009 Sep;175(3):1255-69 |
Prostate |
ICR scid |
PC-3 |
Nucl. Med. Biol. 2009 Oct;36(7):789-800 |
Prostate |
NMRI nude |
PC-3 |
APMIS 2008 May;116(5):382-92 |
Prostate |
C.B-17 scid |
LAPC-4 |
Prostate 2013 May;73(7):754-62 |
Prostate |
C.B-17 scid |
LNCaP |
Prostate 2013 May;73(7):754-62 |
Prostate |
ICR scid |
PC-3 |
Cancer Biother. Radiopharm. 2006 Apr;21(2):155-66 |
Myeloma |
CIEA NOG mouse® |
RPMI-8226 |
Oncotarget 2013 Aug;4(8):1230-40 |
Myeloma |
CIEA NOG mouse® |
NCI-H929 |
Oncotarget 2013 Aug;4(8):1230-40 |
Myeloma |
CIEA NOG mouse® |
U266B1 |
Biochem. Biophys. Res. Commun. 2004 Jan 09;313(2):258-62 |
Myeloma |
C.B-17 scid |
INA-6 |
Clin. Cancer Res. 2009 Dec 01;15(23):7144-52 |
Myeloma |
C.B-17 scid |
INA-6 |
Blood 2009 Jul 09;114(2):371-9 |
Myeloma |
CIEA NOG mouse® |
U266B1 |
Cancer Sci. 2004 Jul;95(7):564-8 |
Myeloma |
CIEA NOG mouse® |
KMM-1 |
Cancer Sci. 2004 Jul;95(7):564-8 |
Mesothelioma |
Scid-beige |
MesoSA1 |
Am. J. Respir. Cell Mol. Biol. 2008 Jun;38(6):671-8 |
Mesothelioma |
CIEA NOG mouse® |
ACC-MESO-1 |
J. Surg. Res. 2011 Oct;170(2):e197-209 |
Melanoma |
BALB/c nude |
SK-MEL-31 |
Cell 2008 Feb 08;132(3):363-74 |
Melanoma |
BALB/c nude |
SK-MEL-28 |
Cell 2008 Feb 08;132(3):363-74 |
Melanoma |
NMRI nude |
G-361 |
Mol. Cancer Ther. 2016 Mar;15(3):354-65 |
Melanoma |
NMRI nude |
A-375 |
Mol. Cancer Ther. 2016 Mar;15(3):354-65 |
Melanoma |
C.B-17 scid |
WM1617 |
Cancer Res. 2012 Oct 01;72(19):5111-8 |
Melanoma |
CIEA NOG mouse® |
HMY-1 |
Oncol. Rep. 2005 Sep;14(3):633-7 |
Melanoma |
CIEA NOG mouse® |
G-361 |
Oncol. Rep. 2005 Sep;14(3):633-7 |
Melanoma |
CIEA NOG mouse® |
A-375 |
Oncol. Rep. 2005 Sep;14(3):633-7 |
Melanoma |
CIEA NOG mouse® |
A2058 |
Oncol. Rep. 2005 Sep;14(3):633-7 |
Melanoma |
Scid-beige |
Mel493 |
Cancer Immunol. Immunother. 2009 Feb;58(2):209-20 |
Melanoma |
Scid-beige |
MeE384 |
Cancer Immunol. Immunother. 2009 Feb;58(2):209-20 |
Melanoma |
C.B-17 scid |
A-375 |
Biochem. Pharmacol. 2009 Aug 15;78(4):344-54 |
Lymphoma |
CIEA NOG mouse® |
SNK6 |
PLoS ONE 2013;8(5):e63566 |
Lymphoma |
CIEA NOG mouse® |
MJ |
Blood 2014 Mar 06;123(10):1499-511 |
Lymphoma |
CIEA NOG mouse® |
HH |
Blood 2014 Mar 06;123(10):1499-511 |
Lymphoma |
CIEA NOG mouse® |
ATN-1 |
Blood 2014 Mar 06;123(10):1499-511 |
Lymphoma |
C.B-17 scid |
WSU-FSCCL |
Blood 2009 Jan 29;113(5):1062-70 |
Lymphoma |
C.B-17 scid |
Daudi |
Blood 2009 Jan 29;113(5):1062-70 |
Lymphoma |
CIEA NOG mouse® |
L-540 |
Cancer Sci. 2005 Aug;96(8):466-73 |
Lymphoma |
CIEA NOG mouse® |
L-428 |
Cancer Sci. 2005 Aug;96(8):466-73 |
Lymphoma |
CIEA NOG mouse® |
KM-H2 |
Cancer Sci. 2005 Aug;96(8):466-73 |
Lymphoma |
CIEA NOG mouse® |
HDLM-2 |
Cancer Sci. 2005 Aug;96(8):466-73 |
Lymphoma |
CIEA NOG mouse® |
TY-1 |
Cancer Sci. 2006 Dec;97(12):1381-7 |
Lymphoma |
CIEA NOG mouse® |
BCBL-1 |
Cancer Sci. 2006 Dec;97(12):1381-7 |
Lung |
Scid-beige |
A549 |
Am. J. Respir. Cell Mol. Biol. 2008 Jun;38(6):671-8 |
Lung |
NCr nude |
NCI-H460 |
Cancer Lett. 2013 Jan 28;328(2):307-17 |
Lung |
NCr nude |
NCI-H2126 |
Comp. Med. 2009 Feb;59(1):37-45 |
Lung |
NCr nude |
NCI-H1975 |
Comp. Med. 2009 Feb;59(1):37-45 |
Lung |
CIEA NOG mouse® |
QG-56 |
Cancer Sci. 2012 Jan;103(1):17-25 |
Lung |
NMRI nude |
GLC19 |
Neoplasia 2006 May;8(5):364-72 |
Lung |
C.B-17 scid |
LT 391-06 |
J Transl Med 2007 Jun 25;5:29 |
Lung |
NMRI nude |
A549 |
APMIS 2008 May;116(5):382-92 |
Lung |
NCr nude |
NCI-H460 |
Clin Lung Cancer 2010 Nov 01;11(6):405-11 |
Lung |
NCr nude |
NCI-H358 |
Clin Lung Cancer 2010 Nov 01;11(6):405-11 |
Lung |
NCr nude |
NCI-H1299 |
Carcinogenesis 2010 Apr;31(4):687-94 |
Lung |
NCr nude |
A549 |
Clin. Cancer Res. 2009 Aug 15;15(16):5136-44 |
Lung |
CIEA NOG mouse® |
T2821 |
Cancers (Basel) 2015 May 22;7(2):876-907 |
Lung |
Rag2 (C57BL/6) |
A549 |
Cancer Res. 2006 Jan 01;66(1):259-66 |
Leukemia |
CIEA NOG mouse® |
NB4 |
Biomed. Pharmacother. 2016 Apr;79:62-70 |
Leukemia |
C.B-17 scid |
Nalm-6-UM1 |
Leuk. Res. 2008 Apr;32(4):625-32 |
Leukemia |
BALB/c nude |
HL-60 |
J. Clin. Invest. 2007 Apr;117(4):1019-28 |
Leukemia |
CIEA NOG mouse® |
MV-4-11 |
J. Pharmacol. Exp. Ther. 2015 Mar;352(3):579-89 |
Leukemia |
CIEA NOG mouse® |
MOLM-13 |
J. Pharmacol. Exp. Ther. 2015 Mar;352(3):579-89 |
Leukemia |
CIEA NOG mouse® |
NB4 |
Leukemia 2004 Mar;18(3):442-8 |
Leukemia |
CIEA NOG mouse® |
TRL-01 |
Cancer Genet. Cytogenet. 2006 Aug;169(1):1-11 |
Leukemia |
CIEA NOG mouse® |
TL-OML |
J. Virol. 2003 May;77(9):5286-94 |
Leukemia |
CIEA NOG mouse® |
MT-1 |
J. Virol. 2003 May;77(9):5286-94 |
Leukemia |
CIEA NOG mouse® |
ED-40515(-) |
J. Virol. 2003 May;77(9):5286-94 |
Leukemia |
Rag2 (BALB/c) |
MOLT-4 |
MAbs 6(4):1000-12 |
Kidney |
Scid-beige |
786-O |
Radiology 2009 Jun;251(3):731-42 |
Kidney |
NMRI nude |
786-O |
J. Virol. 2010 Jan;84(2):856-66 |
Head and neck |
NMRI nude |
FaDu |
J. Nucl. Med. 2016 Mar;57(3):437-43 |
Head and neck |
NMRI nude |
FaDu |
BMC Med Imaging 2016 Jan 14;16:5 |
Glioblastoma |
NCr nude |
U 87 MG |
Biomaterials 2015 Oct;67:1-10 |
Glioblastoma |
ICR scid |
U 87 MG |
Biomaterials 2015 Oct;67:1-10 |
Glioblastoma |
NCr nude |
U 87 MG |
Int. J. Radiat. Oncol. Biol. Phys. 2012 Jan 01;82(1):483-91 |
Glioblastoma |
NMRI nude |
U 87 MG |
Neuro-oncology 2009 Apr;11(2):158-66 |
Glioblastoma |
NCr nude |
U 87 MG |
J Control Release 2007 Oct 08;122(3):356-63 |
Glioblastoma |
NOD scid |
LN-827 |
Genes Cancer 2010 Aug;1(8):822-35 |
Prostate |
NCr nude |
LNCaP |
PLoS ONE 2007 Mar 07;2(3):e267 |
Gallbladder |
BALB/c nude |
Mz-ChA-1 |
Mol. Cancer Res. 2009 Oct;7(10):1704-13 |
Fibrosarcoma |
NCr nude |
HT-1080 |
Cancer Res. 2008 May 01;68(9):3350-60 |
Prostate |
C.B-17 scid |
PC-3 |
Neoplasia 2008 Apr;10(4):371-80 |
Esophageal |
CIEA NOG mouse® |
KE4 |
Cancer Sci. 2012 Jan;103(1):17-25 |
Prostate |
NCr nude |
PC-3 |
Oncogene 2015 Apr 09;34(15):1928-37 |
Prostate |
NCr nude |
DU145 |
Oncogene 2015 Apr 09;34(15):1928-37 |
Colon |
NMRI nude |
COLO 205 |
Mol. Cancer Ther. 2016 Mar;15(3):354-65 |
Colon |
NCr nude |
HCT 116 |
J. Biol. Chem. 2007 Jul 27;282(30):21998-2010 |
Stomach |
ICR scid |
NCI-N87 |
Stem Cells 2009 May;27(5):1006-20 |
Stomach |
Rag2/Il2rg Double Knockout (B6;B10) |
NCI-N87 |
Stem Cells 2009 May;27(5):1006-20 |
Colon |
BALB/c nude |
T84 |
PLoS ONE 2011 Mar 24;6(3):e17532 |
Colon |
BALB/c nude |
HT-29 |
PLoS ONE 2011 Mar 24;6(3):e17532 |
Stomach |
Rag2/Il2rg Double Knockout (B6;B10) |
MKN74 |
Stem Cells 2009 May;27(5):1006-20 |
Stomach |
ICR scid |
MKN74 |
Stem Cells 2009 May;27(5):1006-20 |
Stomach |
ICR scid |
MKN45 |
Stem Cells 2009 May;27(5):1006-20 |
Stomach |
Rag2/Il2rg Double Knockout (B6;B10) |
MKN45 |
Stem Cells 2009 May;27(5):1006-20 |
Colon |
NCr nude |
LS 174T |
Int J Nanomedicine 2010 Oct 05;5:783-802 |
Stomach |
Rag2/Il2rg Double Knockout (B6;B10) |
AGS |
Stem Cells 2009 May;27(5):1006-20 |
Colon |
NMRI nude |
HCT 116 |
APMIS 2008 May;116(5):382-92 |
Colon |
NMRI nude |
HT-29 |
J. Nucl. Med. 2016 Mar;57(3):437-43 |
Colon |
NMRI nude |
HCT 116 |
J Transl Med 2010 Aug 23;8:80 |
Colon |
BALB/c nude |
HCT 116 |
Mol. Cell 2010 Jun 11;38(5):689-99 |
Colon |
CIEA NOG mouse® |
HT-29 |
Int. J. Oncol. 2008 Jan;32(1):153-9 |
Colon |
CIEA NOG mouse® |
LS 174T |
Int. J. Oncol. 2008 Jan;32(1):153-9 |
Colon |
CIEA NOG mouse® |
WiDr |
Int. J. Oncol. 2008 Jan;32(1):153-9 |
Colon |
CIEA NOG mouse® |
LoVo |
Int. J. Oncol. 2008 Jan;32(1):153-9 |
Colon |
CIEA NOG mouse® |
HCT 116 |
Int. J. Oncol. 2008 Jan;32(1):153-9 |
Colon |
CIEA NOG mouse® |
COLO 320DM |
Int. J. Oncol. 2008 Jan;32(1):153-9 |
Colon |
C.B-17 scid |
LS 174T |
Clin. Cancer Res. 2009 Oct 01;15(19):6052-61 |
Colon |
Rag2 (C57BL/6) |
HT-29 |
Mol. Cancer 2014 Nov 05;13:244 |
Colon |
CIEA NOG mouse® |
LS 174T |
Clin. Cancer Res. 2016 Jul 01;22(13):3286-97 |
Cholangiocarcinoma |
CIEA NOG mouse® |
RBE |
Cancer Sci. 2014 Jun;105(6):667-74 |
Cholangiocarcinoma |
CIEA NOG mouse® |
HuCCT1 |
Cancer Sci. 2014 Jun;105(6):667-74 |
Cervical |
CIEA NOG mouse® |
HeLa |
J Toxicol Sci 2009 Feb;34(1):123-7 |
Breast |
NCr nude |
MDA-MB-231 |
Cancer Res. 2009 Aug 01;69(15):6223-31 |
Breast |
CIEA NOG mouse® |
MDA-MB-435_LUC |
Cancer Immunol Res 2015 Jul;3(7):764-76 |
Breast |
NCr nude |
MDA-MB-435 |
Cancer Lett. 2013 Jul 01;334(2):263-73 |
Breast |
CIEA NOG mouse® |
MDA-MB-231 |
PLoS ONE 2014;9(1):e86641 |
Breast |
NCr nude |
MDA-MB-231 |
BMC Cancer 2010 Aug 13;10:427 |
Breast |
CIEA NOG mouse® |
MDA-MB-231 |
Breast Cancer Res. 2012 Oct 25;14(5):R136 |
Breast |
NCr nude |
MDA-MB-231 |
Cancer Res. 2010 Aug 01;70(15):6359-67 |
Breast |
NCr nude |
MCF 10A |
Oncogene 2010 Sep 16;29(37):5204-13 |
Breast |
NMRI nude |
MCF-7 |
APMIS 2008 May;116(5):382-92 |
Breast |
Rag2/Il2rg Double Knockout (B6;B10) |
MDA-MB-231 |
Neoplasia 2007 May;9(5):418-26 |
Breast |
NCr nude |
MDA-MB-435/LCC6 |
Cancer Biol. Ther. 2011 May 01;11(9):826-38 |
Breast |
NCr nude |
MCF-7LU |
BMC Cancer 2010 Mar 22;10:107 |
Breast |
NCr nude |
MCF-7 |
BMC Cancer 2010 Mar 22;10:107 |
Breast |
CIEA NOG mouse® |
MDA-MB-231 |
Biomed. Pharmacother. 2006 Jul;60(6):273-6 |
Breast |
CIEA NOG mouse® |
MCF-7 |
Biomed. Pharmacother. 2006 Jul;60(6):273-6 |
Breast |
NOD scid |
MDA-MB-231 |
Neoplasia 2009 Jun;11(6):509-17, 2 p following 517 |
Breast |
CIEA NOG mouse® |
MDA-MB-231 |
Cancer Lett. 2014 Jul 28;349(2):120-7 |
Breast |
NCr nude |
MDA-MB-231 |
J. Steroid Biochem. Mol. Biol. 2006 Dec;102(1-5):128-38 |
Breast |
BALB/c nude |
MCF-7/TAM2 |
J. Steroid Biochem. Mol. Biol. 2006 Dec;102(1-5):128-38 |
Breast |
BALB/c nude |
MCF-7/RAL2 |
J. Steroid Biochem. Mol. Biol. 2006 Dec;102(1-5):128-38 |
Breast |
BALB/c nude |
MCF-7/RAL1 |
J. Steroid Biochem. Mol. Biol. 2006 Dec;102(1-5):128-38 |
Breast |
BALB/c nude |
MCF-7/E2 |
J. Steroid Biochem. Mol. Biol. 2006 Dec;102(1-5):128-38 |
Breast |
BALB/c nude |
MCF-7 |
J. Steroid Biochem. Mol. Biol. 2006 Dec;102(1-5):128-38 |
Breast |
NCr nude |
MDA-MB-231 |
Br. J. Cancer 2007 Jul 02;97(1):58-64 |
Breast |
NCr nude |
MCF-7 |
Br. J. Cancer 2007 Jul 02;97(1):58-64 |
Bladder |
C.B-17 scid |
URO-MSC24 |
Toxicol. Appl. Pharmacol. 2006 Oct 01;216(1):69-79 |
Bladder |
C.B-17 scid |
URO-ASC |
Toxicol. Appl. Pharmacol. 2006 Oct 01;216(1):69-79 |
Bladder |
NCr nude |
RT4 |
Cancer Prev Res (Phila) 2008 Nov;1(6):439-51 |
Bladder |
BALB/c nude |
KU-19-19 |
Cancer Gene Ther. 2007 Mar;14(3):279-86 |
Bladder |
C.B-17 scid |
UROtsa |
Toxicol. Appl. Pharmacol. 2006 Oct 01;216(1):69-79 |
Bladder |
C.B-17 scid |
URO-MSC52 |
Toxicol. Appl. Pharmacol. 2006 Oct 01;216(1):69-79 |